Optimizing cancer care: specialization, coordination and cooperation

Por Renehan, A G, O'Dwyer, S T
Publicado em 2000

Macroglossia. Classify the pathology as normal or abnormal.

Por Renehan, A. G., Morton, M. E.
Publicado em 1995

Guidelines for colonoscopic screening in acromegaly are inconsistent with those for other high risk groups

Por Renehan, A G, O’Dwyer, S T, Shalet, S M
Publicado em 2003

Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise

Por McGurk, M, Thomas, B L, Renehan, A G
Publicado em 2003

The effect of cigarette smoking use and cessation on serum insulin-like growth factors

Por Renehan, A G, Atkin, W S, O'Dwyer, S T, Shalet, S M
Publicado em 2004

Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis

Por Renehan, A G, Egger, M, Saunders, M P, O'Dwyer, S T
Publicado em 2005

Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer

Por Renehan, A G, Jones, J, Potten, C S, Shalet, S M, O'Dwyer, S T
Publicado em 2000

The interaction between prognostic and pharmacodynamic biomarkers

Por Bouranis, L, Sperrin, M, Greystoke, A, Dive, C, Renehan, A G
Publicado em 2013

Clinico-pathological and treatment-related factors influencing survival in parotid cancer

Por Renehan, A G, Gleave, E N, Slevin, N J, McGurk, M
Publicado em 1999

Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC)

Por Fish, R., Sanders, C., Ryan, N., der Veer, S. Van, Renehan, A. G., Williamson, P. R.
Publicado no Colorectal Dis (2018)

A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei

Por Bibi, R, Pranesh, N, Saunders, M P, Wilson, M S, O'Dwyer, S T, Stern, P L, Renehan, A G
Publicado em 2006

Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer

Por Greystoke, A, Dean, E, Saunders, M P, Cummings, J, Hughes, A, Ranson, M, Dive, C, Renehan, A G
Publicado em 2012

A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei

Por Farquharson, A L, Pranesh, N, Witham, G, Swindell, R, Taylor, M B, Renehan, A G, Rout, S, Wilson, M S, O'Dwyer, S T, Saunders, M P
Publicado em 2008

Reciprocal relationship between expression of hypoxia inducible factor 1α (HIF-1α) and the pro-apoptotic protein Bid in ex vivo colorectal cancer

Por Seenath, M M, Roberts, D, Cawthorne, C, Saunders, M P, Armstrong, G R, O'Dwyer, S T, Stratford, I J, Dive, C, Renehan, A G
Publicado em 2008

Measuring the biological effect of presurgical metformin treatment in endometrial cancer

Por Sivalingam, V N, Kitson, S, McVey, R, Roberts, C, Pemberton, P, Gilmour, K, Ali, S, Renehan, A G, Kitchener, H C, Crosbie, E J
Publicado no Br J Cancer (2016)